Adjuvant chemotherapy with or without bevacizumab in patients with resected non-small-cell lung cancer (E1505): an open-label, multicentre, randomised, phase 3 trial
Lancet Oncol 2017;Published Online November 9, 2017
Health-related quality-of-life results for pembrolizumab versus chemotherapy in advanced, PD-L1-positive NSCLC (KEYNOTE-024): a multicentre, international, randomised, open-label phase 3 trial
Lancet Oncol 2017;Published Online November 9, 2017 http://dx.doi.org/10.1016/S1470-2045(17)30690-3
Osimertinib in Untreated EGFR-Mutated Advanced Non–Small-Cell Lung Cancer
Published on November 18, 2017, at NEJM.org.
Monogenic Diseases of DNA Repair
N Engl J Med 2017;377:1868-76.